Display Settings:


Send to:

Choose Destination
Best Pract Res Clin Rheumatol. 2012 Apr;26(2):225-36. doi: 10.1016/j.berh.2012.03.003.

Taking advances from bench to bedside during the last decade.

Author information

  • 1Division of Clinical Immunology and Rheumatology, Academic Medical Center/University of Amsterdam, The Netherlands. kokmr@maasstadziekenhuis.nl


The remarkable advances in understanding the pathogenesis and therapeutic options for rheumatoid arthritis over the last 10 years are a leap forward in the treatment of this disease. This has led to a shift in focus from established disease to early identification and treatment. Actualisation of treatment guidelines aiming for remission, and a vastly growing arsenal of new synthetic and biological agents have been major achievements. An area of ongoing research is the discovery and development of additional and improved biomarkers for (early) disease with the goal of designing a more personalised treatment regimen to prevent structural tissue damage. Developing valid tools to predict response and outcome for the individual patient remains, however, a great challenge. We will herein summarise some of the major achievements in diagnostic and therapeutic discoveries in rheumatoid arthritis of the past decade.

Copyright © 2012 Elsevier Ltd. All rights reserved.

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk